Literature DB >> 20649096

Pro-insulin, C peptide, glucagon, adiponectin, TNF alpha, AMPK: neglected players in type 2 diabetes mellitus.

R D Lele1.   

Abstract

This article emphasizes (1) the utility of routine measurement of pro-insulin to insulin ratio as a specific marker of insulin resistance and predictor of future T2DM, HT and CAD, (2) routine C-Peptide estimation to determine which T2DM needs insulin and to monitor the effect of newer drugs which promote beta cell regeneration, (3) routine estimation of adiponectin and TNF alpha and monitor response to thiozolidine drugs which increases adiponectin and decreases TNF alpha production by adipocytes, (4) crucial role of AMPK--Cellular energy sensor in mediating the beneficial effects of exercise as well as drugs (adiponectin, metformin) in T2DM, (5) Availability of glucogon suppressors will eliminate the need for giving insulin to T2 DM with normal C Pepetide levels which inevitably causes undesirable weight gain & hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20649096

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  3 in total

1.  Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.

Authors:  Tarek E Korah; Sawsan El-Sayed; Maathir K Elshafie; Ghada E Hammoda; Manal A Safan
Journal:  World J Hepatol       Date:  2013-02-27

Review 2.  Recent Advances in Astragalus membranaceus Anti-Diabetic Research: Pharmacological Effects of Its Phytochemical Constituents.

Authors:  Kojo Agyemang; Lifeng Han; Erwei Liu; Yi Zhang; Tao Wang; Xiumei Gao
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-17       Impact factor: 2.629

3.  Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome.

Authors:  Tetsuro Tamai; Kaori Kamijo; Yoshifusa Abe; Satoshi Hibino; Shunsuke Sakurai; Shuichiro Watanabe; Yoshitaka Watanabe; Satomi Nimura; Atsutoshi Shiratori; Takaaki Takayanagi; Tsuneki Watanabe; Yuya Nakano; Hirokazu Ikeda; Kazushige Dobashi; Yasuko Nakano; Katsumi Mizuno; Kazuo Itabashi
Journal:  Clin Exp Nephrol       Date:  2021-06-01       Impact factor: 2.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.